Author:
Aliagas Elisabet,Villar-Menéndez Izaskun,Sévigny Jean,Roca Mercedes,Romeu Miriam,Ferrer Isidre,Martín-Satué Mireia,Barrachina Marta
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Cellular and Molecular Neuroscience,Molecular Biology
Reference51 articles.
1. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT (2006) Neurobiology of schizophrenia. Neuron 52:139–153. doi: 10.1016/j.neuron.2006.09.015
2. Kegeles LS, Zea-Ponce Y, Abi-Dargham A, Rodenhiser J, Wang T, Weiss R, Van Heertum RL, Mann JJ, Laruelle M (1999) Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans. Synapse 31:302–308
3. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199–214. doi: 10.1001/archpsyc.1994.03950030035004
4. Boison D, Singer P, Shen HY, Feldon J, Yee BK (2012) Adenosine hypothesis of schizophrenia-opportunities for pharmacotherapy. Neuropharmacology 62:1527–1543. doi: 10.1016/j.neuropharm.2011.01.048
5. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527–552
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献